Comparison of Protocol and Indication Biopsies and Their Association with Donor-Specific Antibodies and Treatment Outcomes in Renal Transplant Recipients (TTS 2026) - Sep 17, 2026 - Abstract #P1.158; Pres time: Sep 21, 2026; 04:45 PM - 06:00 PM; Location: Hall 1-2; P1; "Patients diagnosed with SCR were randomized to receive anti-rejection therapy (intravenous methylprednisolone or rituximab) or no additional treatment. Our findings suggest that therapeutic intervention based on protocol biopsy-detected subclinical rejection did not significantly influence graft function or patient outcomes during short-term follow-up."
Biopsy • Clinical • Antibody-mediated Rejection • Transplantation
|
|
Narayan Prasad1; Jeyakumar Meyyappan1; Harshit Singh1; Unnati Srivastava1; Brijendra Yadav1
|